Novo Nordisk Foundation issues grant to support RNA vaccine development in Denmark
A new grant aims to accelerate the development of new RNA-based vaccines against infectious diseases. The goal is spinouts and partnerships, says the leader of the research program.
by albert rønning-andersson, translated by catherine brett
During the Covid-19 pandemic, mRNA vaccines broke records for the speed of their development and adaptability and developers like Pfizer/Biontech and Moderna became household names.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings acquires US-based home infusion therapy firm
For subscribers
Bavarian Nordic predicts vaccine sales will double in 2023
For subscribers
